The global cancer genetic testing market size was valued at USD 6.70 billion in 2024 and is projected to reach from USD 7.47 billion in 2025 to USD 17.98 billion by 2033, growing at a CAGR of 11.6% ...

Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial Colorectal cancer (CRC) remains a major global ...

By Kaplan-Meier analysis, tumor size was a significant predictor of both overall (p = 0.03) and disease-specific (p = 0.02) mortality. However, tumor size approached but did not attain statistical ...

Bob Dylan earns his fortieth career hit on Billboard's Americana/Folk Albums chart as Mixing Up The ... [+] Medicine / A Retrospective debuts. April 1965: American electric folk hero Bob Dylan ...

Jan. 15, 2025 – Prostate cancer is quite common – over 60% of those diagnosed are men over the age of 65 – but it’s not a high priority for cancer researchers. One big reason ...

1Cellular Degradation Biology Center, College of Medicine, Seoul National University, Seoul, Republic of Korea. 2Department of Biomedical Sciences, College of Medicine, Seoul National University, ...

Ontario's health minister says the province will now publicly fund a new treatment for advanced-stage prostate cancer. Health Canada approved Pluvicto in August 2022, but patients have been ...

LONDON — The Ontario government is connecting more people to care by being the first Canadian jurisdiction to publicly fund and administer PLUVICTO TM a new treatment for advanced-stage prostate ...

1Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. 2Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer ...

Prostate and breast cancer were the most common cancer types among participants. Throughout the observed time frame, almost 19% of the participants died, but 65.5% of participants did not ...

This technique is not new. It's used in a process called waterjet ablation (Rezūm therapy) for prostate size reduction due to BPH. This technology was FDA approved in 2015. I had it done in 2019. ...